GANCICLOVIR

GANCICLOVIR was reported 10707 times

GANCICLOVIR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ENCEPHALITIS CYTOMEGALOVIRUS 171 0.3904
1 LUNG DISEASE INFECTIVE EXACERBATION 10 0.3704
2 IMMUNE RECOVERY UVEITIS 21 0.3621
3 CYTOMEGALOVIRUS MYOCARDITIS 11 0.3333
4 OESOPHAGOPLEURAL FISTULA 10 0.3125
5 CYTOMEGALOVIRUS SYNDROME 45 0.2727
6 SMOOTH MUSCLE CELL NEOPLASM 108 0.2584
7 RETINITIS VIRAL 28 0.2314
8 FLAVOBACTERIUM INFECTION 9 0.2045
9 CYTOMEGALOVIRUS GASTRITIS 38 0.1502
10 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 44 0.1477
11 DISSEMINATED CYTOMEGALOVIRAL INFECTION 27 0.1250
12 CYTOMEGALOVIRUS GASTROENTERITIS 27 0.1250
13 NECROTISING HERPETIC RETINOPATHY 9 0.1216
14 KAPOSI SARCOMA INFLAMMATORY CYTOKINE SYNDROME 7 0.1186
15 CYTOMEGALOVIRUS DUODENITIS 8 0.1143
16 AUTOIMMUNE PANCYTOPENIA 10 0.1099
17 CYTOMEGALOVIRUS OESOPHAGITIS 39 0.1060
18 CYTOMEGALOVIRUS CHORIORETINITIS 203 0.1040
19 CYTOMEGALOVIRUS VIRAEMIA 434 0.0975
20 PNEUMONIA CYTOMEGALOVIRAL 188 0.0967
21 EPSTEIN-BARR VIRAEMIA 105 0.0947
22 BK POLYOMAVIRUS TEST POSITIVE 9 0.0938
23 CYTOMEGALOVIRUS ANTIGEN POSITIVE 17 0.0929
24 CYTOMEGALOVIRUS INFECTION REACTIVATION 397 0.0898
25 CYTOMEGALOVIRUS COLITIS 197 0.0856
26 ACANTHAMOEBA INFECTION 16 0.0851
27 VIRAL UVEITIS 8 0.0825
28 ADENOVIRUS REACTIVATION 11 0.0764
29 NEUTROPHIL PELGER-HUET ANOMALY PRESENT 14 0.0749
30 DRUG RESISTANCE MUTATION 13 0.0730
31 CYTOMEGALOVIRUS ENTERITIS 26 0.0730
32 CYTOMEGALOVIRUS INFECTION 1208 0.0726
33 TRACTIONAL RETINAL DETACHMENT 8 0.0721
34 MESANGIOPROLIFERATIVE GLOMERULONEPHRITIS 11 0.0719
35 CYTOMEGALOVIRUS HEPATITIS 25 0.0706
36 VIRAL HAEMORRHAGIC CYSTITIS 50 0.0702
37 CYTOMEGALOVIRUS ENTEROCOLITIS 51 0.0662
38 NECROTISING RETINITIS 41 0.0641
39 INTRACRANIAL INFECTION 8 0.0640
40 GRAFT VERSUS HOST DISEASE IN INTESTINE 8 0.0615
41 SELECTIVE IGA IMMUNODEFICIENCY 9 0.0612
42 HUMAN HERPESVIRUS 8 INFECTION 37 0.0608
43 GASTROINTESTINAL MUCORMYCOSIS 10 0.0599
44 PARVOVIRUS INFECTION 24 0.0594
45 RHEGMATOGENOUS RETINAL DETACHMENT 12 0.0574
46 INFECTED NEOPLASM 14 0.0562
47 CYTOMEGALOVIRUS TEST POSITIVE 100 0.0561
48 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 78 0.0552
49 PARVOVIRUS B19 INFECTION 49 0.0547
50 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 265 0.0520
51 BK VIRUS INFECTION 175 0.0518
52 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 68 0.0516
53 SCEDOSPORIUM INFECTION 36 0.0510
54 IDIOPATHIC PNEUMONIA SYNDROME 15 0.0503
55 CYSTITIS HAEMORRHAGIC 202 0.0501
56 UREAPLASMA INFECTION 19 0.0466
57 HUMAN HERPESVIRUS 6 ENCEPHALITIS 13 0.0458
58 BRONCHIOLITIS OBLITERANS SYNDROME 8 0.0457
59 BRONCHOALVEOLAR LAVAGE ABNORMAL 9 0.0433
60 ADENOVIRAL HAEMORRHAGIC CYSTITIS 9 0.0433
61 GLOMERULOSCLEROSIS 27 0.0427
62 ADENOVIRAL HEPATITIS 10 0.0426
63 CONFABULATION 11 0.0415
64 EPSTEIN-BARR VIRUS INFECTION 256 0.0409
65 HERPES SIMPLEX TEST POSITIVE 8 0.0402
66 COMPLICATIONS OF TRANSPLANTED LUNG 12 0.0391
67 BACTERIAL TRANSLOCATION 12 0.0379
68 FUNGAL SEPSIS 31 0.0373
69 LUNG TRANSPLANT REJECTION 24 0.0364
70 GRAFT VERSUS HOST DISEASE IN SKIN 80 0.0363
71 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 26 0.0362
72 URINARY TRACT INFLAMMATION 13 0.0361
73 DISSEMINATED MUCORMYCOSIS 14 0.0355
74 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 62 0.0350
75 ENGRAFT FAILURE 10 0.0348
76 ADENOVIRUS INFECTION 100 0.0344
77 FUSARIUM INFECTION 24 0.0343
78 KERATITIS FUNGAL 7 0.0337
79 EYE INFECTION FUNGAL 13 0.0336
80 PNEUMOCYSTIS JIROVECII INFECTION 40 0.0335
81 GRAFT VERSUS HOST DISEASE IN LUNG 16 0.0335
82 COMPLICATIONS OF TRANSPLANTED LIVER 12 0.0333
83 ENTEROCOLITIS VIRAL 10 0.0329
84 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 70 0.0329
85 PATHOGEN RESISTANCE 297 0.0326
86 ACUTE ON CHRONIC LIVER FAILURE 7 0.0324
87 PULMONARY NECROSIS 11 0.0323
88 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 89 0.0322
89 BLADDER HYPERTROPHY 14 0.0317
90 BURKHOLDERIA CEPACIA COMPLEX INFECTION 9 0.0315
91 OPHTHALMIC HERPES SIMPLEX 18 0.0312
92 GLOMERULONEPHROPATHY 8 0.0312
93 ACUTE GRAFT VERSUS HOST DISEASE 143 0.0312
94 CONDUCTIVE DEAFNESS 10 0.0312
95 GRAFT VERSUS HOST DISEASE 224 0.0311
96 RETINAL ISCHAEMIA 19 0.0311
97 INCISION SITE PAIN 36 0.0306
98 CD4 LYMPHOCYTES INCREASED 7 0.0300
99 RED BLOOD CELLS URINE POSITIVE 29 0.0300
100 BLOOD BETA-D-GLUCAN INCREASED 9 0.0293
101 MORAXELLA INFECTION 8 0.0292
102 INFECTION REACTIVATION 33 0.0288
103 TRANSPLANT REJECTION 229 0.0286
104 RED BLOOD CELL SCHISTOCYTES PRESENT 9 0.0278
105 TOXOPLASMOSIS 30 0.0278
106 CEREBRAL ASPERGILLOSIS 17 0.0276
107 ACINETOBACTER INFECTION 30 0.0274
108 DRUG RESISTANCE 678 0.0264
109 HUMAN POLYOMAVIRUS INFECTION 14 0.0264
110 ENCEPHALITIS HERPES 13 0.0263
111 INTUSSUSCEPTION 25 0.0262
112 RETINAL SCAR 12 0.0260
113 CENTRAL NERVOUS SYSTEM NECROSIS 7 0.0255
114 CEREBRAL TOXOPLASMOSIS 23 0.0246
115 ASPERGILLOSIS 32 0.0245
116 TRANSPLANT DYSFUNCTION 41 0.0230
117 ADRENAL MASS 19 0.0229
118 STENOTROPHOMONAS INFECTION 31 0.0228
119 HUMAN HERPESVIRUS 6 INFECTION 43 0.0227
120 ASPERGILLUS TEST POSITIVE 7 0.0227
121 ENTEROCOCCAL BACTERAEMIA 24 0.0226
122 POLYOMAVIRUS VIRAEMIA 24 0.0226
123 CONGENITAL APLASIA 7 0.0225
124 ENTEROCOCCAL INFECTION 108 0.0223
125 GRAFT LOSS 16 0.0221
126 ASPERGILLUS INFECTION 144 0.0219
127 NEPHROPATHY TOXIC 244 0.0217
128 CHRONIC GRAFT VERSUS HOST DISEASE 77 0.0213
129 CYSTITIS VIRAL 8 0.0209
130 THROMBOTIC MICROANGIOPATHY 200 0.0205
131 BRAIN COMPRESSION 8 0.0200
132 PHARYNGEAL ABSCESS 10 0.0199
133 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 149 0.0198
134 MUCORMYCOSIS 51 0.0196
135 GRAFT VERSUS HOST DISEASE IN LIVER 14 0.0196
136 VIRAEMIA 27 0.0195
137 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 18 0.0194
138 IMMUNE RECONSTITUTION SYNDROME 25 0.0194
139 KLEBSIELLA INFECTION 98 0.0194
140 SEPTIC EMBOLUS 16 0.0192
141 MACULAR FIBROSIS 13 0.0192
142 RESPIRATORY TRACT INFECTION FUNGAL 10 0.0189
143 ENGRAFTMENT SYNDROME 11 0.0186
144 ECZEMA NUMMULAR 9 0.0184
145 HERPES SIMPLEX REACTIVATION 7 0.0184
146 LIVER TRANSPLANT REJECTION 33 0.0184
147 TRANSPLANT FAILURE 45 0.0183
148 INFECTION IN AN IMMUNOCOMPROMISED HOST 13 0.0181
149 LOWER RESPIRATORY TRACT INFECTION FUNGAL 7 0.0180
150 CHRONIC ALLOGRAFT NEPHROPATHY 14 0.0179
151 COMPLICATIONS OF TRANSPLANTED KIDNEY 40 0.0176
152 T-LYMPHOCYTE COUNT DECREASED 12 0.0176
153 PSEUDOMONAL BACTERAEMIA 15 0.0176
154 KIDNEY TRANSPLANT REJECTION 84 0.0175
155 TRACHEOBRONCHITIS 13 0.0169
156 DELAYED GRAFT FUNCTION 12 0.0169
157 MENINGITIS VIRAL 23 0.0168
158 GENITAL LESION 7 0.0165
159 PNEUMOCYSTIS JIROVECII PNEUMONIA 165 0.0164
160 PNEUMONIA PSEUDOMONAL 25 0.0163
161 RENAL TRANSPLANT FAILURE 16 0.0162
162 MARROW HYPERPLASIA 11 0.0161
163 KIDNEY FIBROSIS 28 0.0161
164 OESOPHAGITIS ULCERATIVE 11 0.0161
165 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 37 0.0158
166 GASTRIC FISTULA 7 0.0157
167 DIFFUSE ALVEOLAR DAMAGE 18 0.0157
168 MENINGOENCEPHALITIS HERPETIC 7 0.0156
169 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 25 0.0156
170 BRONCHOPULMONARY ASPERGILLOSIS 120 0.0155
171 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 51 0.0154
172 BACTERIAL SEPSIS 50 0.0153
173 HYPHAEMA 8 0.0153
174 METAPNEUMOVIRUS INFECTION 12 0.0153
175 OBLITERATIVE BRONCHIOLITIS 20 0.0152
176 DISSEMINATED ASPERGILLOSIS 7 0.0148
177 APLASIA PURE RED CELL 51 0.0148
178 MULTIPLE ORGAN DYSFUNCTION SYNDROME 416 0.0147
179 SYSTEMIC MYCOSIS 17 0.0146
180 VARICELLA ZOSTER VIRUS INFECTION 30 0.0145
181 STRONGYLOIDIASIS 23 0.0142
182 PULMONARY MYCOSIS 11 0.0141
183 BRAIN HERNIATION 42 0.0140
184 ENCEPHALITIS VIRAL 17 0.0140
185 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 8 0.0135
186 ALVEOLAR PROTEINOSIS 8 0.0135
187 NEUROLOGICAL DECOMPENSATION 31 0.0134
188 HYPERPLASIA 12 0.0133
189 RETINITIS 23 0.0133
190 BOTULISM 11 0.0133
191 CAMPYLOBACTER INFECTION 11 0.0132
192 STREPTOCOCCAL BACTERAEMIA 14 0.0129
193 VIRAL LOAD INCREASED 50 0.0129
194 FUNGAEMIA 20 0.0127
195 INTRACRANIAL MASS 12 0.0127
196 CORNEAL PERFORATION 8 0.0127
197 BONE MARROW TOXICITY 15 0.0127
198 ABDOMINAL COMPARTMENT SYNDROME 8 0.0126
199 VENOOCCLUSIVE DISEASE 31 0.0124
200 RENAL TUBULAR INJURY 15 0.0123
201 VENOOCCLUSIVE LIVER DISEASE 61 0.0123
202 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 61 0.0122
203 NEPHROGENIC DIABETES INSIPIDUS 14 0.0121
204 LYMPHOCELE 8 0.0120
205 VIRAL MUTATION IDENTIFIED 44 0.0119
206 GRAFT COMPLICATION 7 0.0119
207 RETINAL VASCULITIS 14 0.0118
208 COMPUTERISED TOMOGRAM THORAX ABNORMAL 8 0.0116
209 ACTINIC KERATOSIS 30 0.0115
210 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 9 0.0114
211 PNEUMONIA KLEBSIELLA 21 0.0114
212 RENAL TUBULAR ATROPHY 10 0.0113
213 HERPES ZOSTER DISSEMINATED 9 0.0112
214 PSEUDOMONAS INFECTION 96 0.0112
215 PROTEUS INFECTION 8 0.0111
216 HYPOPROTEINAEMIA 21 0.0111
217 PNEUMONIA STREPTOCOCCAL 12 0.0109
218 OSMOTIC DEMYELINATION SYNDROME 8 0.0108
219 PNEUMONIA CRYPTOCOCCAL 10 0.0106
220 KLEBSIELLA BACTERAEMIA 10 0.0105
221 PNEUMOMEDIASTINUM 19 0.0105
222 NEUTROPENIC INFECTION 10 0.0104
223 LYMPHADENOPATHY MEDIASTINAL 20 0.0104
224 ARTERIAL RUPTURE 8 0.0104
225 APLASTIC ANAEMIA 54 0.0103
226 STAPHYLOCOCCAL SEPSIS 51 0.0103
227 MULTIPLE-DRUG RESISTANCE 32 0.0103
228 SUBCUTANEOUS EMPHYSEMA 10 0.0102
229 SUPERINFECTION BACTERIAL 8 0.0101
230 LUNG ABSCESS 21 0.0100
231 URETERIC STENOSIS 8 0.0100
232 RENAL TUBULAR DISORDER 28 0.0099
233 BRAIN ABSCESS 25 0.0099
234 LYMPHOPROLIFERATIVE DISORDER 29 0.0099
235 CEREBRAL ARTERY EMBOLISM 12 0.0098
236 KLEBSIELLA SEPSIS 11 0.0098
237 ESCHERICHIA SEPSIS 28 0.0097
238 HYPOGAMMAGLOBULINAEMIA 62 0.0094
239 HISTIOCYTOSIS HAEMATOPHAGIC 28 0.0094
240 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 25 0.0094
241 PANCYTOPENIA 525 0.0094
242 ESCHERICHIA BACTERAEMIA 22 0.0093
243 HYPERLACTACIDAEMIA 25 0.0093
244 PULMONARY CAVITATION 8 0.0092
245 PNEUMOCYSTIS JIROVECI PNEUMONIA 20 0.0090
246 IMMUNE THROMBOCYTOPENIA 41 0.0089
247 LEUKAEMIA RECURRENT 15 0.0089
248 NEUROPSYCHIATRIC SYMPTOMS 8 0.0089
249 LYMPHOPENIA 124 0.0088
250 ENTEROCOCCAL SEPSIS 7 0.0086
251 DYSBIOSIS 7 0.0085
252 ENCEPHALITIS 59 0.0085
253 MICROANGIOPATHY 8 0.0085
254 SYSTEMIC CANDIDA 21 0.0084
255 BICYTOPENIA 16 0.0082
256 PNEUMONIA VIRAL 26 0.0081
257 OPPORTUNISTIC INFECTION 15 0.0081
258 STEROID DIABETES 12 0.0080
259 OPTIC ATROPHY 13 0.0080
260 ILEAL ULCER 8 0.0079
261 MYCOBACTERIUM AVIUM COMPLEX INFECTION 21 0.0078
262 RETINAL TOXICITY 8 0.0078
263 EPIDIDYMITIS 9 0.0077
264 LARGE INTESTINAL ULCER 21 0.0077
265 ENTEROBACTER INFECTION 13 0.0077
266 RETINAL DEGENERATION 10 0.0077
267 GASTROINTESTINAL VIRAL INFECTION 8 0.0077
268 HERPES OPHTHALMIC 10 0.0076
269 OESOPHAGEAL CANDIDIASIS 30 0.0075
270 PNEUMONIA BACTERIAL 69 0.0075
271 BILE DUCT STENOSIS 9 0.0075
272 CLOSTRIDIUM DIFFICILE COLITIS 78 0.0073
273 CYTOPENIA 90 0.0073
274 HAEMOLYTIC URAEMIC SYNDROME 17 0.0073
275 URETERIC OBSTRUCTION 10 0.0073
276 SQUAMOUS CELL CARCINOMA OF SKIN 44 0.0073
277 CENTRAL NERVOUS SYSTEM LYMPHOMA 10 0.0073
278 LEUKOPENIA 363 0.0072
279 VITREOUS HAEMORRHAGE 20 0.0072
280 ABDOMINAL INFECTION 18 0.0070
281 PULMONARY HAEMORRHAGE 55 0.0070
282 CD4 LYMPHOCYTES DECREASED 15 0.0070
283 PLATELET TRANSFUSION 9 0.0070
284 ACUTE MYELOID LEUKAEMIA RECURRENT 15 0.0070
285 HERPES SIMPLEX 45 0.0069
286 RESTRICTIVE PULMONARY DISEASE 8 0.0068
287 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 26 0.0068
288 CRYPTOCOCCOSIS 11 0.0067
289 HEART TRANSPLANT REJECTION 7 0.0067
290 APRAXIA 10 0.0067
291 HEPATOSPLENOMEGALY 17 0.0066
292 OLIGURIA 41 0.0066
293 CLOSTRIDIUM COLITIS 8 0.0066
294 PARAINFLUENZAE VIRUS INFECTION 10 0.0066
295 GENERALISED OEDEMA 80 0.0065
296 BONE MARROW FAILURE 131 0.0064
297 HAEMORRHAGE INTRACRANIAL 96 0.0064
298 ADENOCARCINOMA OF COLON 12 0.0064
299 GASTROINTESTINAL ULCER 14 0.0063
300 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 7 0.0063
301 LIP HAEMORRHAGE 8 0.0063
302 PSEUDOMEMBRANOUS COLITIS 14 0.0063
303 JC VIRUS INFECTION 10 0.0063
304 NOROVIRUS INFECTION 9 0.0062
305 SEPTIC SHOCK 270 0.0062
306 MULTI-ORGAN FAILURE 106 0.0061
307 CENTRAL NERVOUS SYSTEM INFECTION 7 0.0061
308 PNEUMONIA FUNGAL 24 0.0061
309 GENE MUTATION 12 0.0061
310 LYMPHOCYTOSIS 13 0.0060
311 DISSEMINATED INTRAVASCULAR COAGULATION 85 0.0060
312 IMMUNE-MEDIATED LUNG DISEASE 11 0.0060
313 MYELOSUPPRESSION 217 0.0060
314 GASTROINTESTINAL STROMAL TUMOUR 16 0.0060
315 HYPERAMMONAEMIA 30 0.0060
316 ACUTE RESPIRATORY DISTRESS SYNDROME 106 0.0060
317 DEVICE RELATED SEPSIS 12 0.0060
318 END STAGE RENAL DISEASE 108 0.0059
319 LEUKOENCEPHALOPATHY 22 0.0059
320 NOSOCOMIAL INFECTION 13 0.0059
321 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 56 0.0059
322 CORNEAL OPACITY 8 0.0059
323 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 7 0.0058
324 RESPIRATORY DISTRESS 160 0.0058
325 MENINGITIS CRYPTOCOCCAL 10 0.0057
326 BACTERAEMIA 67 0.0056
327 PROTEIN URINE PRESENT 28 0.0056
328 BILIRUBIN CONJUGATED INCREASED 13 0.0056
329 STAPHYLOCOCCAL BACTERAEMIA 24 0.0055
330 HEPATITIS CHOLESTATIC 33 0.0055
331 NOCARDIOSIS 14 0.0055
332 RESPIRATORY FAILURE 399 0.0055
333 OESOPHAGEAL ULCER 21 0.0055
334 NORMOCYTIC ANAEMIA 8 0.0054
335 RETINAL DETACHMENT 50 0.0054
336 QUADRIPARESIS 9 0.0054
337 EYELID PAIN 11 0.0054
338 ENTEROCOLITIS 31 0.0054
339 MACULAR OEDEMA 30 0.0053
340 ENCEPHALITIS AUTOIMMUNE 7 0.0053
341 CYSTOID MACULAR OEDEMA 10 0.0053
342 SECONDARY ADRENOCORTICAL INSUFFICIENCY 8 0.0053
343 MECHANICAL VENTILATION 10 0.0053
344 LIVER ABSCESS 17 0.0052
345 GASTROINTESTINAL NECROSIS 15 0.0051
346 HYPOALBUMINAEMIA 40 0.0051
347 URINARY TRACT INFECTION BACTERIAL 13 0.0051
348 PSEUDOMONAL SEPSIS 9 0.0051
349 HAEMORRHAGE URINARY TRACT 13 0.0051
350 CACHEXIA 26 0.0050
351 ORGANISING PNEUMONIA 25 0.0050
352 HISTOPLASMOSIS DISSEMINATED 8 0.0050
353 INTRA-ABDOMINAL HAEMORRHAGE 12 0.0050
354 CANDIDA INFECTION 84 0.0050
355 GASTRIC ULCER 93 0.0049
356 PNEUMOPERITONEUM 9 0.0049
357 BRAIN DEATH 15 0.0048
358 RETINAL HAEMORRHAGE 34 0.0048
359 LUNG INFILTRATION 42 0.0048
360 HAEMODYNAMIC INSTABILITY 36 0.0047
361 RETINAL OEDEMA 9 0.0047
362 PULMONARY TUBERCULOSIS 20 0.0047
363 HYPERCAPNIA 14 0.0046
364 INFECTIOUS PLEURAL EFFUSION 7 0.0046
365 MULTI-ORGAN DISORDER 9 0.0046
366 HAEMATOTOXICITY 43 0.0045
367 COMA SCALE ABNORMAL 13 0.0045
368 ORGAN FAILURE 18 0.0045
369 MEGACOLON 7 0.0045
370 HYDROCEPHALUS 24 0.0044
371 ENTERITIS 28 0.0044
372 SOFT TISSUE INFECTION 8 0.0044
373 LYMPHOCYTE COUNT DECREASED 76 0.0043
374 ESCHERICHIA INFECTION 35 0.0043
375 CANDIDIASIS 17 0.0042
376 DUODENITIS 13 0.0042
377 NEUTROPHIL COUNT INCREASED 43 0.0042
378 CEREBRAL HAEMATOMA 14 0.0042
379 HYPERBILIRUBINAEMIA 43 0.0041
380 IRIDOCYCLITIS 13 0.0041
381 MALNUTRITION 46 0.0041
382 CORNEAL DISORDER 9 0.0041
383 PULMONARY ALVEOLAR HAEMORRHAGE 23 0.0041
384 PYELONEPHRITIS ACUTE 8 0.0041
385 PNEUMONIA STAPHYLOCOCCAL 8 0.0041
386 NEUTROPENIA 548 0.0040
387 SPLENOMEGALY 47 0.0040
388 STEM CELL TRANSPLANT 10 0.0040
389 RENAL IMPAIRMENT 336 0.0040
390 LUNG INFECTION 62 0.0040
391 RENAL TUBULAR NECROSIS 39 0.0040
392 BONE MARROW DISORDER 12 0.0040
393 HISTOPLASMOSIS 7 0.0040
394 TOXIC ENCEPHALOPATHY 20 0.0039
395 OTITIS MEDIA 13 0.0039
396 SHOCK HAEMORRHAGIC 32 0.0039
397 HYPERURICAEMIA 16 0.0039
398 BLOOD UREA INCREASED 65 0.0039
399 CAPILLARY LEAK SYNDROME 8 0.0039
400 BLOOD HIV RNA INCREASED 7 0.0039
401 CEREBRAL VENOUS THROMBOSIS 7 0.0039
402 LUNG OPACITY 10 0.0038
403 SEPSIS 420 0.0038
404 DIFFUSE LARGE B-CELL LYMPHOMA 29 0.0038
405 TOXIC EPIDERMAL NECROLYSIS 57 0.0037
406 VASCULAR DEVICE INFECTION 17 0.0037
407 ELECTROLYTE IMBALANCE 43 0.0037
408 ACUTE RESPIRATORY FAILURE 71 0.0037
409 TUBULOINTERSTITIAL NEPHRITIS 69 0.0037
410 TACHYPNOEA 50 0.0037
411 ULCERATIVE KERATITIS 10 0.0036
412 NEPHROGENIC SYSTEMIC FIBROSIS 11 0.0036
413 HYPERTRANSAMINASAEMIA 25 0.0036
414 PARESIS 8 0.0036
415 FIBROSIS 11 0.0036
416 BRAIN OEDEMA 45 0.0036
417 BRONCHIECTASIS 24 0.0036
418 CHOLANGITIS 22 0.0035
419 ESCHERICHIA URINARY TRACT INFECTION 15 0.0035
420 AUTOIMMUNE HAEMOLYTIC ANAEMIA 12 0.0035
421 BACTERIAL INFECTION 65 0.0035
422 HEPATITIS B REACTIVATION 11 0.0035
423 HAEMODIALYSIS 29 0.0034
424 HYPOMAGNESAEMIA 48 0.0034
425 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 189 0.0034
426 MUCOSAL INFLAMMATION 90 0.0034
427 DIARRHOEA HAEMORRHAGIC 32 0.0034
428 IMMUNOSUPPRESSION 30 0.0034
429 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 20 0.0034
430 ASCITES 99 0.0034
431 GASTROINTESTINAL INFECTION 30 0.0033
432 THROMBOCYTOPENIA 370 0.0033
433 GUILLAIN-BARRE SYNDROME 16 0.0033
434 AUTOIMMUNE HEPATITIS 23 0.0033
435 KERATITIS 10 0.0033
436 CLONUS 9 0.0033
437 PNEUMOTHORAX 52 0.0033
438 BLOOD ALBUMIN DECREASED 26 0.0033
439 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 27 0.0033
440 B-CELL LYMPHOMA 11 0.0032
441 HYPERVOLAEMIA 16 0.0032
442 LUNG CONSOLIDATION 9 0.0032
443 HEPATIC NECROSIS 12 0.0032
444 ACUTE LYMPHOCYTIC LEUKAEMIA 9 0.0032
445 HERPES VIRUS INFECTION 18 0.0031
446 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 19 0.0031
447 PNEUMONITIS 85 0.0031
448 LARGE INTESTINAL HAEMORRHAGE 7 0.0031
449 COLITIS 118 0.0031
450 HYPOPHOSPHATAEMIA 23 0.0031
451 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 8 0.0031
452 HEPATIC FAILURE 93 0.0031
453 HEPATIC FUNCTION ABNORMAL 114 0.0031
454 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 8 0.0031
455 LIVER TRANSPLANT 11 0.0030
456 AGRANULOCYTOSIS 56 0.0030
457 FUNGAL INFECTION 98 0.0029
458 CHOLESTASIS 56 0.0029
459 LYMPHADENITIS 7 0.0029
460 SUSPECTED OFF LABEL USE 13 0.0029
461 GLOMERULONEPHRITIS 7 0.0029
462 HAEMOLYSIS 22 0.0028
463 HYDRONEPHROSIS 21 0.0028
464 RESPIRATORY ACIDOSIS 11 0.0028
465 HYPERTRIGLYCERIDAEMIA 16 0.0027
466 IMMUNE-MEDIATED ENTEROCOLITIS 10 0.0027
467 PLEURAL EFFUSION 165 0.0027
468 ATYPICAL PNEUMONIA 8 0.0027
469 BLOOD CULTURE POSITIVE 8 0.0027
470 WOUND DEHISCENCE 9 0.0027
471 CLOSTRIDIAL INFECTION 9 0.0027
472 HEPATOMEGALY 26 0.0026
473 BRONCHOPNEUMONIA 9 0.0026
474 HEPATIC FIBROSIS 9 0.0026
475 ATAXIA 31 0.0026
476 DERMATITIS EXFOLIATIVE 13 0.0026
477 INTERSTITIAL LUNG DISEASE 125 0.0026
478 SHOCK 59 0.0026
479 INTESTINAL ISCHAEMIA 14 0.0025
480 HEPATITIS 65 0.0025
481 FEBRILE NEUTROPENIA 168 0.0025
482 CEREBRAL ISCHAEMIA 13 0.0025
483 FOREIGN BODY SENSATION IN EYES 16 0.0025
484 ENDOPHTHALMITIS 15 0.0025
485 GASTROINTESTINAL TOXICITY 12 0.0025
486 ENDOTRACHEAL INTUBATION 7 0.0025
487 STUPOR 8 0.0025
488 ENCEPHALOPATHY 61 0.0025
489 NEPHROTIC SYNDROME 17 0.0025
490 DEVICE RELATED INFECTION 38 0.0025
491 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8 0.0025
492 NYSTAGMUS 13 0.0024
493 ANURIA 21 0.0024
494 UVEITIS 33 0.0024
495 ORAL CANDIDIASIS 32 0.0024
496 HYPERLIPIDAEMIA 29 0.0024
497 CARDIAC DYSFUNCTION 9 0.0024
498 HYPERNATRAEMIA 12 0.0024
499 HIGH DENSITY LIPOPROTEIN DECREASED 8 0.0024
500 TUMOUR LYSIS SYNDROME 21 0.0024
501 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 61 0.0024
502 BLOOD CREATININE INCREASED 151 0.0023
503 FAILURE TO THRIVE 12 0.0023
504 LARGE INTESTINE PERFORATION 16 0.0023
505 TONSILLITIS 12 0.0023
506 ASPIRATION 25 0.0023
507 GRANULOCYTOPENIA 13 0.0023
508 NEUROLOGICAL SYMPTOM 13 0.0023
509 DEPRESSIVE SYMPTOM 8 0.0023
510 CEREBRAL HAEMORRHAGE 81 0.0023
511 HYPOKALAEMIA 104 0.0023
512 BASAL CELL CARCINOMA 35 0.0022
513 RENAL FAILURE ACUTE 95 0.0022
514 PRODUCT USE IN UNAPPROVED INDICATION 552 0.0022
515 NEUROTOXICITY 39 0.0022
516 THERAPY NON-RESPONDER 100 0.0022
517 ABDOMINAL TENDERNESS 11 0.0022
518 SCLERODERMA 8 0.0022
519 MYOPATHY 19 0.0022
520 ODYNOPHAGIA 13 0.0022
521 HYPOXIA 76 0.0022
522 RENAL FAILURE 286 0.0022
523 RETINOPATHY 8 0.0021
524 HYPERPYREXIA 9 0.0021
525 HEMIPARESIS 36 0.0021
526 AUTOIMMUNE THYROIDITIS 8 0.0021
527 ACUTE KIDNEY INJURY 323 0.0021
528 BLOOD BILIRUBIN INCREASED 57 0.0021
529 NEUTROPENIC SEPSIS 15 0.0021
530 MENINGITIS 14 0.0021
531 LYMPHADENOPATHY 74 0.0021
532 LEFT VENTRICULAR DYSFUNCTION 14 0.0021
533 BLOOD LACTIC ACID INCREASED 11 0.0021
534 HYPOVOLAEMIC SHOCK 10 0.0021
535 HYPERKALAEMIA 73 0.0021
536 ATELECTASIS 20 0.0021
537 RALES 12 0.0021
538 METABOLIC ACIDOSIS 66 0.0021
539 C-REACTIVE PROTEIN INCREASED 75 0.0021
540 LUNG DISORDER 101 0.0021
541 DRUG LEVEL INCREASED 34 0.0021
542 HYPOVOLAEMIA 12 0.0020
543 VENOUS THROMBOSIS 8 0.0020
544 COVID-19 PNEUMONIA 24 0.0020
545 ILEUS PARALYTIC 9 0.0020
546 CREATININE RENAL CLEARANCE DECREASED 8 0.0020
547 FACIAL PARALYSIS 17 0.0020
548 HEPATOTOXICITY 44 0.0020
549 INTRACRANIAL PRESSURE INCREASED 11 0.0020
550 OFF LABEL USE 1720 0.0020
551 ACIDOSIS 15 0.0020
552 INTESTINAL PERFORATION 22 0.0020
553 EOSINOPHILIA 34 0.0019
554 PHOTOPHOBIA 36 0.0019
555 STAPHYLOCOCCAL INFECTION 63 0.0019
556 PERICARDIAL EFFUSION 44 0.0019
557 CENTRAL NERVOUS SYSTEM LESION 26 0.0019
558 PERIPHERAL SENSORY NEUROPATHY 11 0.0019
559 ALTERED STATE OF CONSCIOUSNESS 40 0.0018
560 DECUBITUS ULCER 15 0.0018
561 PULMONARY TOXICITY 13 0.0018
562 PERITONITIS 38 0.0018
563 CLOSTRIDIUM DIFFICILE INFECTION 40 0.0018
564 ACUTE HEPATIC FAILURE 25 0.0018
565 HEPATIC ENCEPHALOPATHY 17 0.0018
566 LEUKAEMIA 17 0.0018
567 RASH MACULO-PAPULAR 40 0.0018
568 NECROSIS 10 0.0018
569 CYTOKINE RELEASE SYNDROME 36 0.0018
570 EYE PAIN 101 0.0018
571 GASTROINTESTINAL INFLAMMATION 14 0.0018
572 HAEMOLYTIC ANAEMIA 16 0.0018
573 MENINGITIS ASEPTIC 8 0.0018
574 INTENTIONAL PRODUCT USE ISSUE 156 0.0018
575 TREATMENT FAILURE 147 0.0018
576 WHITE BLOOD CELL COUNT INCREASED 68 0.0018
577 ENDOCARDITIS 9 0.0018
578 PYREXIA 607 0.0018
579 LYMPHOMA 27 0.0017
580 MYOCARDITIS 20 0.0017
581 PROTEINURIA 33 0.0017
582 PYELONEPHRITIS 15 0.0017
583 HAEMATURIA 59 0.0017
584 LIVER FUNCTION TEST ABNORMAL 50 0.0017
585 GASTROENTERITIS 25 0.0017
586 PLEURISY 10 0.0017
587 METASTASIS 12 0.0017
588 DRUG LEVEL DECREASED 17 0.0017
589 PRODUCT USE ISSUE 310 0.0016
590 BLOOD LACTATE DEHYDROGENASE INCREASED 26 0.0016
591 LIVER INJURY 40 0.0016
592 UROSEPSIS 15 0.0016
593 COAGULOPATHY 27 0.0016
594 ABDOMINAL ABSCESS 7 0.0016
595 RIGHT VENTRICULAR FAILURE 11 0.0016
596 DUODENAL ULCER 11 0.0016
597 GASTRITIS 41 0.0016
598 ANAEMIA 297 0.0016
599 NEUTROPHIL COUNT DECREASED 63 0.0015
600 VASCULITIS 18 0.0015
601 HYPONATRAEMIA 86 0.0015
602 DERMATITIS BULLOUS 11 0.0015
603 SERUM FERRITIN INCREASED 8 0.0015
604 SKIN INFECTION 17 0.0015
605 RENAL CYST 12 0.0015
606 DRUG-INDUCED LIVER INJURY 47 0.0015
607 TYPE 1 DIABETES MELLITUS 9 0.0015
608 URINE OUTPUT DECREASED 13 0.0015
609 POSTOPERATIVE WOUND INFECTION 10 0.0015
610 GENERAL PHYSICAL CONDITION ABNORMAL 10 0.0015
611 DISEASE PROGRESSION 171 0.0014
612 AUTOIMMUNE DISORDER 14 0.0014
613 PLATELET COUNT DECREASED 152 0.0014
614 STATUS EPILEPTICUS 16 0.0014
615 GASTROINTESTINAL HAEMORRHAGE 118 0.0014
616 TORSADE DE POINTES 11 0.0014
617 HYPERGLYCAEMIA 51 0.0014
618 CARDIOGENIC SHOCK 20 0.0014
619 CARDIAC ARREST 115 0.0014
620 BLOOD URIC ACID INCREASED 8 0.0014
621 HEPATITIS ACUTE 9 0.0014
622 EYELID PTOSIS 14 0.0014
623 POLYP 9 0.0014
624 RESPIRATORY DISORDER 41 0.0014
625 ALANINE AMINOTRANSFERASE INCREASED 84 0.0014
626 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 14 0.0014
627 CIRCULATORY COLLAPSE 23 0.0013
628 OCULAR DISCOMFORT 15 0.0013
629 HEPATIC CYTOLYSIS 17 0.0013
630 LEUKOCYTOSIS 24 0.0013
631 HEPATITIS C 16 0.0013
632 PNEUMONIA 429 0.0013
633 COLITIS ULCERATIVE 59 0.0013
634 TRANSAMINASES INCREASED 29 0.0013
635 POST PROCEDURAL COMPLICATION 25 0.0013
636 GRAND MAL CONVULSION 12 0.0013
637 NEPHROPATHY 12 0.0013
638 ACUTE MYELOID LEUKAEMIA 20 0.0013
639 WOUND INFECTION 14 0.0013
640 PAPULE 9 0.0013
641 DIALYSIS 18 0.0013
642 GAMMA-GLUTAMYLTRANSFERASE INCREASED 28 0.0013
643 DISEASE RECURRENCE 60 0.0013
644 CHOLECYSTITIS 15 0.0013
645 HERPES ZOSTER 72 0.0013
646 UPPER GASTROINTESTINAL HAEMORRHAGE 21 0.0012
647 LIVER DISORDER 55 0.0012
648 INFECTION 177 0.0012
649 THERAPY PARTIAL RESPONDER 19 0.0012
650 HYPOCALCAEMIA 23 0.0012
651 HYPERCALCAEMIA 15 0.0012
652 SKIN LESION 33 0.0012
653 CARDIAC FAILURE ACUTE 8 0.0012
654 JAUNDICE 32 0.0012
655 PULMONARY OEDEMA 53 0.0012
656 ASPARTATE AMINOTRANSFERASE INCREASED 62 0.0012
657 DEPRESSED LEVEL OF CONSCIOUSNESS 46 0.0012
658 HEPATITIS B 7 0.0012
659 ADRENAL INSUFFICIENCY 14 0.0012
660 PULMONARY HYPERTENSION 24 0.0012
661 RESPIRATORY TRACT INFECTION 30 0.0012
662 FOETAL GROWTH RESTRICTION 7 0.0012
663 GENERALISED TONIC-CLONIC SEIZURE 19 0.0011
664 NO THERAPEUTIC RESPONSE 14 0.0011
665 PULMONARY FIBROSIS 22 0.0011
666 WHITE BLOOD CELL COUNT DECREASED 124 0.0011
667 CONDITION AGGRAVATED 346 0.0011
668 HAEMOGLOBIN DECREASED 116 0.0011
669 DRUG INEFFECTIVE 1484 0.0011
670 STEVENS-JOHNSON SYNDROME 25 0.0011
671 EPILEPSY 34 0.0011
672 MOUTH HAEMORRHAGE 8 0.0011
673 MENTAL STATUS CHANGES 30 0.0011
674 BLOOD TRIGLYCERIDES INCREASED 19 0.0011
675 PERICARDITIS 18 0.0011
676 HEPATOCELLULAR INJURY 15 0.0011
677 SMALL INTESTINAL OBSTRUCTION 13 0.0011
678 PETECHIAE 11 0.0011
679 HEPATOCELLULAR CARCINOMA 8 0.0011
680 FOLLICULITIS 11 0.0010
681 BLOOD ALKALINE PHOSPHATASE INCREASED 26 0.0010
682 ILEUS 13 0.0010
683 MELAENA 23 0.0010
684 PNEUMONIA ASPIRATION 26 0.0010
685 UPPER RESPIRATORY TRACT INFECTION 48 0.0010
686 DRUG TOXICITY 14 0.0010
687 EYE MOVEMENT DISORDER 7 0.0010
688 ECCHYMOSIS 7 0.0010
689 PURPURA 9 0.0010
690 ANOREXIA 13 0.0010
691 PANCREATITIS 53 0.0010
692 MOUTH ULCERATION 21 0.0010
693 VIRAL INFECTION 33 0.0010
694 SINUS TACHYCARDIA 14 0.0010
695 POLYURIA 8 0.0010
696 CONJUNCTIVITIS 18 0.0010
697 MYELODYSPLASTIC SYNDROME 14 0.0010
698 VISUAL ACUITY REDUCED 32 0.0010
699 EYE IRRITATION 55 0.0010
700 CARDIOMYOPATHY 14 0.0009
701 MUSCLE ATROPHY 12 0.0009
702 PULMONARY MASS 14 0.0009
703 INTRAOCULAR PRESSURE INCREASED 12 0.0009
704 PANCREATITIS ACUTE 21 0.0009
705 ORAL HERPES 18 0.0009
706 RESPIRATORY SYNCYTIAL VIRUS INFECTION 8 0.0009
707 DIABETES MELLITUS 70 0.0009
708 PULMONARY CONGESTION 12 0.0009
709 HEPATIC CIRRHOSIS 17 0.0009
710 DRUG ERUPTION 16 0.0009
711 HAEMOPTYSIS 25 0.0009
712 MYOSITIS 8 0.0009
713 STOMATITIS 53 0.0009
714 GASTROINTESTINAL DISORDER 78 0.0009
715 NEOPLASM 10 0.0009
716 PROCEDURAL PAIN 24 0.0009
717 URINARY TRACT INFECTION 147 0.0009
718 RENAL DISORDER 40 0.0009
719 ERYTHEMA MULTIFORME 8 0.0009
720 TACHYCARDIA 75 0.0008
721 OCULAR HYPERAEMIA 40 0.0008
722 EYE INFLAMMATION 8 0.0008
723 HYPOTENSION 168 0.0008
724 BLINDNESS 34 0.0008
725 DRUG INTERACTION 132 0.0008
726 LACRIMATION INCREASED 25 0.0008
727 FLUID OVERLOAD 12 0.0008
728 BLOOD MAGNESIUM DECREASED 7 0.0008
729 CARDIAC FAILURE 65 0.0008
730 OBSTRUCTIVE AIRWAYS DISORDER 9 0.0008
731 DELIRIUM 28 0.0008
732 COMA 38 0.0008
733 HAEMATOCHEZIA 44 0.0008
734 CELLULITIS 40 0.0008
735 HEPATIC ENZYME INCREASED 54 0.0008
736 TOXICITY TO VARIOUS AGENTS 132 0.0008
737 EYELID OEDEMA 9 0.0008
738 POST PROCEDURAL HAEMORRHAGE 9 0.0008
739 ATRIAL FIBRILLATION 75 0.0008
740 SUBDURAL HAEMATOMA 11 0.0008
741 MYOCLONUS 9 0.0008
742 RASH ERYTHEMATOUS 36 0.0008
743 OXYGEN SATURATION DECREASED 42 0.0007
744 GENERAL PHYSICAL HEALTH DETERIORATION 86 0.0007
745 BLOOD URINE PRESENT 14 0.0007
746 CONVULSION 42 0.0007
747 GLOMERULAR FILTRATION RATE DECREASED 9 0.0007
748 OESOPHAGITIS 8 0.0007
749 SEROTONIN SYNDROME 14 0.0007
750 PRESCRIBED OVERDOSE 14 0.0007
751 RASH PAPULAR 16 0.0007
752 FISTULA 8 0.0007
753 BLOOD CALCIUM DECREASED 8 0.0007
754 BLINDNESS UNILATERAL 10 0.0007
755 REBOUND EFFECT 8 0.0007
756 EJECTION FRACTION DECREASED 11 0.0007
757 DYSURIA 26 0.0007
758 INTERNATIONAL NORMALISED RATIO INCREASED 20 0.0007
759 DIARRHOEA 450 0.0007
760 THROMBOSIS 56 0.0007
761 SKIN DISORDER 23 0.0007
762 ABSCESS 11 0.0007
763 IMMUNE SYSTEM DISORDER 9 0.0007
764 GLAUCOMA 13 0.0007
765 ABDOMINAL PAIN 157 0.0007
766 HAEMATEMESIS 17 0.0007
767 POLYNEUROPATHY 8 0.0007
768 APHASIA 20 0.0007
769 HAEMATOCRIT DECREASED 13 0.0007
770 CEREBRAL INFARCTION 16 0.0007
771 CARDIOMEGALY 8 0.0006
772 NERVOUS SYSTEM DISORDER 20 0.0006
773 OSTEONECROSIS 21 0.0006
774 BLOOD CREATINE PHOSPHOKINASE INCREASED 18 0.0006
775 PULMONARY ARTERIAL HYPERTENSION 9 0.0006
776 HYPOKINESIA 9 0.0006
777 UNRESPONSIVE TO STIMULI 16 0.0006
778 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 18 0.0006
779 KIDNEY INFECTION 12 0.0006
780 OEDEMA 33 0.0006
781 RHABDOMYOLYSIS 25 0.0006
782 CYSTITIS 19 0.0006
783 FULL BLOOD COUNT DECREASED 12 0.0006
784 OSTEOPENIA 9 0.0006
785 BODY TEMPERATURE INCREASED 12 0.0006
786 PALLOR 16 0.0006
787 IMPAIRED GASTRIC EMPTYING 8 0.0006
788 SEIZURE 67 0.0006
789 DIPLOPIA 15 0.0006
790 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 41 0.0006
791 CONFUSIONAL STATE 92 0.0006
792 HALLUCINATION, VISUAL 12 0.0006
793 PREMATURE DELIVERY 9 0.0006
794 EYE SWELLING 21 0.0006
795 BLOOD PRESSURE DECREASED 37 0.0006
796 BLOOD POTASSIUM INCREASED 9 0.0006
797 VISION BLURRED 76 0.0006
798 CARDIO-RESPIRATORY ARREST 23 0.0005
799 VISUAL IMPAIRMENT 68 0.0005
800 HYPOPHAGIA 14 0.0005
801 PRODUCT ADMINISTRATION ERROR 11 0.0005
802 HIATUS HERNIA 7 0.0005
803 IMMUNODEFICIENCY 8 0.0005
804 OSTEOPOROSIS 22 0.0005
805 INTESTINAL OBSTRUCTION 20 0.0005
806 TREATMENT NONCOMPLIANCE 29 0.0005
807 CHRONIC KIDNEY DISEASE 40 0.0005
808 HYPERTENSION 108 0.0005
809 DISORIENTATION 20 0.0005
810 GASTROENTERITIS VIRAL 9 0.0005
811 LACTIC ACIDOSIS 16 0.0005
812 DYSKINESIA 20 0.0005
813 PULMONARY EMBOLISM 46 0.0005
814 MUSCLE TWITCHING 11 0.0005
815 ARRHYTHMIA 22 0.0005
816 HALLUCINATION 35 0.0005
817 MENTAL DISORDER 20 0.0005
818 DIABETIC KETOACIDOSIS 11 0.0005
819 RED BLOOD CELL COUNT DECREASED 13 0.0005
820 DYSPHAGIA 43 0.0005
821 URINARY RETENTION 15 0.0004
822 OEDEMA PERIPHERAL 54 0.0004
823 OSTEOMYELITIS 8 0.0004
824 SKIN EXFOLIATION 37 0.0004
825 RENAL INJURY 13 0.0004
826 ACCIDENTAL OVERDOSE 16 0.0004
827 BRADYCARDIA 23 0.0004
828 PREMATURE BABY 13 0.0004
829 DEHYDRATION 57 0.0004
830 DRUG INTOLERANCE 41 0.0004
831 WEIGHT DECREASED 118 0.0004
832 LIVER FUNCTION TEST INCREASED 9 0.0004
833 RECTAL HAEMORRHAGE 18 0.0004
834 PRODUCTIVE COUGH 20 0.0004
835 BLOOD PRESSURE FLUCTUATION 10 0.0004
836 INFLUENZA 46 0.0004
837 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
838 NIGHT SWEATS 13 0.0004
839 BLOOD POTASSIUM DECREASED 12 0.0004
840 CHROMATURIA 9 0.0004
841 COUGH 110 0.0004
842 DECREASED APPETITE 91 0.0004
843 GOUT 7 0.0004
844 COGNITIVE DISORDER 18 0.0004
845 AMNESIA 25 0.0004
846 AGITATION 28 0.0004
847 NEUROPATHY PERIPHERAL 36 0.0004
848 RASH MACULAR 13 0.0004
849 VOMITING 174 0.0004
850 PRODUCT PRESCRIBING ISSUE 8 0.0004
851 IMPAIRED HEALING 12 0.0004
852 RESPIRATORY ARREST 10 0.0004
853 EPISTAXIS 27 0.0004
854 COVID-19 63 0.0004
855 ABDOMINAL PAIN LOWER 9 0.0004
856 DEEP VEIN THROMBOSIS 23 0.0004
857 MUSCULAR WEAKNESS 40 0.0004
858 BONE DENSITY DECREASED 11 0.0004
859 ANGINA PECTORIS 10 0.0003
860 HAEMATOMA 9 0.0003
861 INFUSION RELATED REACTION 23 0.0003
862 DYSARTHRIA 13 0.0003
863 ANHEDONIA 9 0.0003
864 ACUTE MYOCARDIAL INFARCTION 10 0.0003
865 LABORATORY TEST ABNORMAL 10 0.0003
866 CHOLELITHIASIS 11 0.0003
867 DERMATITIS 7 0.0003
868 PLASMA CELL MYELOMA 13 0.0003
869 CHILLS 39 0.0003
870 RASH PRURITIC 18 0.0003
871 MOOD ALTERED 9 0.0003
872 INFLAMMATION 17 0.0003
873 ABDOMINAL DISTENSION 34 0.0003
874 DRY EYE 16 0.0003
875 LETHARGY 18 0.0003
876 CHEST DISCOMFORT 32 0.0003
877 MOVEMENT DISORDER 10 0.0003
878 RASH 135 0.0003
879 SKIN ULCER 8 0.0003
880 HYPOGLYCAEMIA 15 0.0003
881 JOINT STIFFNESS 8 0.0003
882 CATARACT 18 0.0003
883 UNDERDOSE 22 0.0003
884 BLOOD CHOLESTEROL INCREASED 14 0.0003
885 ANGIOEDEMA 13 0.0003
886 DYSPNOEA EXERTIONAL 11 0.0003
887 NEOPLASM PROGRESSION 10 0.0003
888 ERYTHEMA 59 0.0003
889 HAEMORRHAGE 30 0.0003
890 NEPHROLITHIASIS 13 0.0003
891 MALIGNANT NEOPLASM PROGRESSION 29 0.0003
892 PAIN IN JAW 8 0.0003
893 THERAPEUTIC RESPONSE DECREASED 17 0.0003
894 ASTHENIA 104 0.0003
895 NO ADVERSE EVENT 50 0.0003
896 EYE DISORDER 9 0.0003
897 EXPOSURE DURING PREGNANCY 17 0.0003
898 MYALGIA 46 0.0003
899 URINARY INCONTINENCE 8 0.0003
900 DYSPNOEA 152 0.0003
901 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
902 RHINORRHOEA 17 0.0003
903 FOETAL EXPOSURE DURING PREGNANCY 21 0.0003
904 MATERNAL EXPOSURE DURING PREGNANCY 23 0.0003
905 BRONCHITIS 19 0.0003
906 MUSCULOSKELETAL PAIN 13 0.0002
907 NAUSEA 192 0.0002
908 TINNITUS 11 0.0002
909 BLOOD GLUCOSE INCREASED 45 0.0002
910 CHEST PAIN 43 0.0002
911 CONSTIPATION 50 0.0002
912 HEART RATE DECREASED 8 0.0002
913 LOSS OF CONSCIOUSNESS 29 0.0002
914 POLLAKIURIA 9 0.0002
915 GAIT INABILITY 7 0.0002
916 EYE PRURITUS 7 0.0002
917 MEDICATION ERROR 11 0.0002
918 FLUID RETENTION 10 0.0002
919 SINUSITIS 20 0.0002
920 LUNG NEOPLASM MALIGNANT 8 0.0002
921 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
922 MALAISE 83 0.0002
923 DEATH 162 0.0002
924 BONE PAIN 11 0.0002
925 BALANCE DISORDER 16 0.0002
926 OROPHARYNGEAL PAIN 17 0.0002
927 TREMOR 30 0.0002
928 ABDOMINAL DISCOMFORT 30 0.0002
929 SOMNOLENCE 36 0.0002
930 BLISTER 10 0.0002
931 CARDIAC FAILURE CONGESTIVE 14 0.0002
932 HEADACHE 108 0.0002
933 SLEEP DISORDER 12 0.0002
934 HYPOAESTHESIA 25 0.0002
935 ANAPHYLACTIC REACTION 9 0.0002
936 OVERDOSE 35 0.0002
937 DYSGEUSIA 12 0.0002
938 SYNCOPE 16 0.0002
939 INFLUENZA LIKE ILLNESS 13 0.0002
940 THERAPY INTERRUPTED 11 0.0002
941 HYPERSENSITIVITY 28 0.0002
942 DRY SKIN 20 0.0001
943 IRRITABILITY 9 0.0001
944 EMOTIONAL DISTRESS 18 0.0001
945 INJURY 10 0.0001
946 PAIN IN EXTREMITY 41 0.0001
947 GASTROOESOPHAGEAL REFLUX DISEASE 11 0.0001
948 CEREBROVASCULAR ACCIDENT 23 0.0001
949 NASOPHARYNGITIS 25 0.0001
950 WHEEZING 8 0.0001
951 VERTIGO 8 0.0001
952 HEART RATE INCREASED 13 0.0001
953 MOBILITY DECREASED 9 0.0001
954 MEMORY IMPAIRMENT 17 0.0001
955 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 22 0.0001
956 DYSPEPSIA 12 0.0001
957 FALL 39 0.0001
958 PARAESTHESIA 18 0.0001
959 MUSCULOSKELETAL STIFFNESS 10 0.0001
960 DEPRESSION 25 0.0001
961 BACK PAIN 25 0.0001
962 PAIN 66 0.0001
963 SWELLING 10 0.0001
964 BLOOD PRESSURE INCREASED 16 0.0001
965 FATIGUE 81 0.0001
966 INTENTIONAL PRODUCT MISUSE 9 0.0001
967 ABDOMINAL PAIN UPPER 21 0.0001
968 INSOMNIA 27 0.0001
969 GAIT DISTURBANCE 19 0.0001
970 DIZZINESS 49 0.0001
971 WEIGHT INCREASED 22 0.0001
972 PERIPHERAL SWELLING 15 0.0001
973 ILLNESS 10 0.0001
974 MIGRAINE 9 0.0001
975 PRURITUS 35 0.0001
976 URTICARIA 15 0.0001
977 MYOCARDIAL INFARCTION 15 0.0001
978 CARDIAC DISORDER 8 0.0001
979 ARTHRALGIA 35 0.0001
980 CONTUSION 8 0.0001
981 JOINT SWELLING 10 0.0001
982 PRODUCT DOSE OMISSION ISSUE 23 0.0001
983 HOSPITALISATION 12 0.0001
984 HYPERHIDROSIS 10 0.0001
985 ANXIETY 21 0.0001
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 14 0.0001
987 PALPITATIONS 8 0.0001
988 ALOPECIA 13 0.0001
989 INCORRECT DOSE ADMINISTERED 15 0.0001
990 ASTHMA 7 0.0001
991 PRODUCT QUALITY ISSUE 8 0.0001
992 DRUG DOSE OMISSION 7 0.0000
993 MUSCLE SPASMS 7 0.0000